Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Nature Communications|August 25, 2022
Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signalingHongxing Shen, Fengyuan Huang, Xiangmin Zhang, et al.
Advances in Radiation Oncology|May 8, 2023
Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United StatesAnn C Raldow, Malika L Siker, James A Bonner, et al.
Nature Communications|October 31, 2024
HIF1α-regulated glycolysis promotes activation-induced cell death and IFN-γ induction in hypoxic T cellsHongxing Shen, Oluwagbemiga A Ojo, Haitao Ding, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancerSteven E Schild, Philip J Stella, Susan M Geyer, et al.
International Journal of Oncology|December 20, 2014
Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivityTimothy D Rohrbach, John S Jarboe, Joshua C Anderson, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2019
Gender, Professional Experiences, and Personal Characteristics of Academic Radiation Oncology Chairs: Data to Inform the Pipeline for the 21st CenturyWhitney H Beeler, Kent A Griffith, Rochelle D Jones, et al.
International Journal of Oncology|April 4, 2019
Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastomaNicholas J Eustace, Joshua C Anderson, Catherine P Langford, et al.
The New England Journal of Medicine|February 10, 2006
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neckJames A Bonner, Paul M Harari, Jordi Giralt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2012
MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for gliomaJohn S Jarboe, Joshua C Anderson, Christine W Duarte, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancerSteven E Schild, James A Bonner, Thomas G Shanahan, et al.
Pageof 12